ClinicalTrials.gg
Sign In
CompletedNCT07884682Updated Oct 20, 2026

Virtual Reality for Pain and Anxiety During Intravenous Catheterization

An interventional study of virtual reality glass in VR, Pain and Anxiety, sponsored by Erzincan Binali Yildirim Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Erzincan Binali Yildirim Universitesi · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Mar 2025, registered Oct 2026).
Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study was conducted as a quasi-experimental study with a pretest-posttest control group design to determine the effect of using VRG, as a distraction method, on pain, anxiety, oxygen saturation level, and pulse rate during PIC.

02

Conditions studied

  • VR
  • Pain
  • Anxiety
03

In context

Pain

2,450 studies on the registry are indexed under Pain; 945 are open to participants now.

This study's enrollment of 136 is above the median of 70 across 2,101 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Erzincan Binali Yildirim Universitesi is the lead sponsor of 23 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-65 years old,
  • had no verbal,
  • perceptual, or visual communication difficulties,
  • had not taken analgesic medication within the previous 24 hours,
  • had no fever at admission,
  • reported no acute or chronic pain,
  • had no previous history of syncope during PIC insertion

Exclusion criteria

Exclusion Criteria:

  • requested to leave the study,
  • felt unwell during PIC insertion,
  • were receiving chemotherapy,
  • had a previous surgical procedure in the planned insertion area,
  • had scarring, psoriasis, or active dermatitis at the insertion site,
  • required more than one attempt for PIC placement, or had undergone an invasive procedure in the same vein within the previous month
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
136 participants (actual)

Study arms

  • Experimental
    Virtual Reality During Intravenous Catheterization

    Other: virtual reality glass

  • No intervention
    Standard Care During Intravenous Catheterization

Interventions

  • Othervirtual reality glass

    virtual reality glass

06

What researchers measure

Primary outcomes

  1. Physiological Symptoms of Anxiety Follow-Up Form

    Time frame: Before and after the peripheral venous catheter insertion procedure

  2. Visual Analog Scale for Pain

    Time frame: Before and after the peripheral venous catheter insertion procedure

  3. Visual Analog Scale for Anxiety

    Time frame: Before and after the peripheral venous catheter insertion procedure

  4. Virtual Reality Glasses Satisfaction Form

    Time frame: After the peripheral venous catheter insertion procedure

07

Study locations

1 site
  • A Training and Research Hospital
    Erzincan, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07884682
Lead sponsor
Erzincan Binali Yildirim Universitesi
Responsible party
Şengül KORKMAZ BİNAY (Assistant Professor, Erzincan Binali Yildirim Universitesi) — Principal investigator
First posted
Oct 20, 2026
Start date
Mar 20, 2025
Primary completion
Aug 30, 2025
Completion
Aug 30, 2025
Last update
Oct 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pain →

Other studies from this sponsor

Erzincan Binali Yildirim Universitesi

Start the discussion